• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Retinoids and retinoic acid metabolism blocking agents in combination with histone deacetylase inhibitors for prostate cancer therapy

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Find Full text
    Author
    Khandelwal, Aakanksha
    Advisor
    Njar, Vincent
    Date
    2007
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    All-trans-retinoic acid (ATRA), a metabolite of vitamin A, is 5 to 8 times lower in prostate carcinoma tissue when compared to a normal prostate and benign prostatic hyperplasia. ATRA plays a major role in a number of biological processes and is metabolized by cytochrome P450 enzymes into inactive polar metabolites. The anticancer effects of a novel class of agents called atypical retinoic acid metabolism blocking agents (RAMBAs) were examined in combination with histone deacetylase inhibitors (HDACIs). The purpose of this study was to select combinations of agents which would have potent anti-cancer activities in a hormone insensitive prostate cancer model. One particular RAMBA, VN/66-1 which displays favorable pharmacokinetics and minimal toxicity was found to be highly potent in inhibiting PC-3 cell growth. Two HDACIs, SAHA and MS-275 were also found to be potent in inhibiting PC-3 cell viability. The combinations of VN/66-1 + MS-275 and VN/66-1 + SAHA synergistically inhibited PC-3 cell growth caused cytotoxicity/cytostaticity. Treatment of PC-3 xenografts with VN/66-1 (10 mg/kg/day) + MS-275 (2.5 mg/kg/day) for 18 days resulted in an 85% reduction in final mean tumor volume compared with control. The combination of VN/66-1 + SAHA, however, did not reduce tumor growth as effectively as the two agents individually most likely due to too low doses. The data obtained suggest that the mechanism of action of the combination of VN/66-1 + MS-275 is through apoptosis and DNA damage-induced p21 WAF1/CIP1 activation. Active p21 is involved in the inhibition of the cdc2-cyclin B1 complex resulting in eventual G2/M phase arrest. This induction of p21 is also in part due to the enhancement of acetylation of histones H3 and H4 which is also responsible for the activation of tumor suppressor gene RARbeta2, the latter which also plays a role in mediating cell death. Up-regulation of Bad and down-regulation of Bcl-2 as well as PARP cleavage indicated that apoptosis via the intrinsic pathway is also contributing to cell death. Together, these results suggest that VN/66-1 or its combination with MS-275 may be a novel therapy for the treatment of hormone refractory prostate carcinoma.
    Description
    University of Maryland, Baltimore. Pharmacology and Experimental Therapeutics. Ph.D. 2007
    Keyword
    Health Sciences, Pharmacology
    Health Sciences, Oncology
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/1066
    Collections
    Theses and Dissertations All Schools
    Theses and Dissertations School of Medicine

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.